UNSPSC 51123101: Acecainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C15H23N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 910Q707V6F, chemically known as benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)- but more generally known as acecainide, which bears US NIH Compound Identifier 4342. Acecainide most often appears in forms base and hydrochloride.

UNSPSC 51123101 Acecainide is a Commodity code representing specific emergency and acute-care pharmaceuticals procured by state and local health agencies, fire departments, and pharmacy benefit programs. State and local governments buy acecainide and related advanced life support medications—typically in measured units with strict expiration and shelf-life requirements—for emergency medical services, hospital systems, and state pharmacy benefit programs. The issuing bodies include city fire departments (Tampa Fire Rescue), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances coordinating procurement across state and local government healthcare facilities.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications including epinephrine, adenosine, labetalol, and diltiazem—four specific line items totaling an estimated $40,000 with a response deadline of April 8, 2026 and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount capped at $10,000. The Texas Health and Human Services Commission posted RFI HHS0017013 in early April 2026 seeking vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit managers and group purchasing organizations, signaling emerging interest in alternative supply-chain models for state drug procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson), with proposals due March 26, 2026 and pricing weighted at 75 percent of evaluation criteria; the resulting contract becomes effective July 1, 2026, with a two-year initial term and optional extensions through June 30, 2028.